Abstract LB-094: Hepavac-101 first-in-man clinical trial of a multi-peptide-based vaccine for hepatocellular carcinoma
Year: 2020
Type: conference-abstract
Source: Cancer Research
Authors: Luigi Buonaguro, Andrea Mayer, Markus Loeffler, Sarah Missel, Roberto Accolla, Yuk Ting Ma, Tanguy Chaumette, Regina Heidenreich, Alfred Königsrainer, Joerg Ludwig, Diego Alcoba, Heiko Schuster, Cecile Gouttenfangeas, Greta Forlani, Maria Tagliamonte, Paolo A. Ascierto, Antonio Avallone, Marco Borrelli, Hans-Georg Rammensee, Bruno Sangro, Mercedes Iñarrairaegui, Sven Francque, Luisa Vonghia, Stefania Gori, Tony Weinschenk, Carsten Reinhardt, Ulrike Gnad-Vogt, Harpreet Singh
Institutions: Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale", Immatics Biotechnologies (Germany), University of Tübingen, University of Insubria, University of Birmingham, Université de Nantes, Nantes Université, CureVac (Germany), Clinica Universidad de Navarra, Antwerp University Hospital, Ospedale Sacro Cuore Don Calabria
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W3083468942